The therapeutic landscape of multiple sclerosis has undergone a remarkable transformation over the past two decades. The paradigm has shifted from reliance on moderate-efficacy, first-generation injectable therapies toward earlier adoption of high-efficacy disease-modifying treatments, particularly in relapsing forms of MS. This evolution reflects an increasing focus on early intensive treatment strategies aimed at preserving long-term neurological function and brain health.
The article focuses on the management of anesthesia in obstetric patients with multiple sclerosis (MS). It presents a case study of a 25-year-old pregnant woman with relapsing-remitting MS and epilepsy, who required an urgent cesarean delivery. The study discusses the choice between general and neuraxial anesthesia, emphasizing the potential risks associated with each. Neuraxial epidural anesthesia was used successfully, and the patient's condition was monitored for one year postpartum. The article highlights the lack of extensive studies on anesthetic techniques for pregnant women with MS and suggests that using epidural anesthesia at the minimum effective concentration can reduce risks.